The Patent Finder
CP

Concert Pharmaceuticals, Inc.

First filing 2006
OverviewNotableFeesChangesFamiliesPatent listSources & methods

8 patents currently held

92 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.

The next term ends in Apr 2028. from the record

Of the 92 now held by other companies, 86 name Sun Pharmaceutical Industries Inc. as their current owner, and 6 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
8
Ending by 2030
Apr 2028
Next term end
1
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents fee due within 90 days all others Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.

Formerly held, still cited

Notable
Cited by 60 later US patents, top 10% of utility patents granted in 2015 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Ends no later than Mar 2029 · Low confidence
Also notable
Cited by 85 later US patents, top 10% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030.
Ends Aug 2030 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 7, 2027
    The maintenance fee for Morphinan Compounds (US 9,072,711) comes due Jan 7, 2027. Unpaid by Jul 7, 2027, it lapses early.
  • 1 fee due Oct 19, 2027
    The maintenance fee for Morphinan Compounds (US 9,314,440) comes due Oct 19, 2027. Unpaid by Apr 19, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 21, 2026

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
Morphinan Compounds8 in forceto Apr 2030

Patents held now

Soonest term end first.

Showing 1 to 8 of 8

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 8,188,110Morphinan Compounds
In force
 · High confidence
In forceHigh confidence
US 8,541,436Morphinan Compounds
In force
 · High confidence
In forceHigh confidence
US 9,072,711Morphinan Compounds
In force
 · High confidence
In forceHigh confidence
US 9,314,440Morphinan Compounds
In force
 · High confidence
In forceHigh confidence
US 9,868,976Morphinan Compounds
In force
 · High confidence
In forceHigh confidence
US 11,473,123Morphinan Compounds
In force
 · High confidence
In forceHigh confidence
US 12,319,954Morphinan Compounds
In force
 · High confidence
In forceHigh confidence
US 7,973,049Morphinan Compounds
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 8: 92 patents in force now held by others · 42 patents ended · 10 applications pending · 121 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
18 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed
9 computed term dates come from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited